Deflazacort Oral Suspension
Product Images NDC 27808-249

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Deflazacort Oral Suspension (NDC 27808-249). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cranbury Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tris Chemdraw Structure (Deflazacort Oral Suspension 1)

FDA Label Image

Figurei (Deflazacort Oral Suspension 10)

FDA Label Image

Figurej (Deflazacort Oral Suspension 11)

FDA Label Image

Figurek (Deflazacort Oral Suspension 12)

FDA Label Image

Figurel (Deflazacort Oral Suspension 13)

FDA Label Image

Label (Deflazacort Oral Suspension 14)

This is a description of Deflazacort Oral Suspension with a concentration of 22.75 mg/mL for oral administration. Each mL contains 2275 mg of deflazacort. The medication is to be stored at 20° to 25°C (68°F to 77°F) with excursions permitted to 15° to 30°C (59°F to 86°F). The package is child-resistant, and it is recommended to close tightly after opening. The manufacturer is Tis Pharma, Inc. based in Monmouth Junction, NJ with additional details provided for usage and storage.*

FDA Label Image

Figurea (Deflazacort Oral Suspension 2)

This text describes a package containing Deflazacort oral suspension in a carton along with a bottle, bottle adapter, and a household cup for dispensing the medication orally.*

FDA Label Image

Figureb (Deflazacort Oral Suspension 3)

FDA Label Image

Figurec (Deflazacort Oral Suspension 4)

FDA Label Image

Figured (Deflazacort Oral Suspension 5)

This text provides instructions on how to use a bottle adapter. It states to press down on the adapter using both thumbs. This simple and clear description guides the user on how to use the product effectively.*

FDA Label Image

Figuree (Deflazacort Oral Suspension 6)

FDA Label Image

Figuref (Deflazacort Oral Suspension 7)

FDA Label Image

Figureg (Deflazacort Oral Suspension 8)

This text provides guidance on how to measure the dose from the widest part of the plunger. It suggests a method for ensuring accurate dosage administration.*

FDA Label Image

Figureh (Deflazacort Oral Suspension 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.